The year in cardiology 2012: Acute coronary syndromes

European Heart Journal

Volumn 34, Issue 6, 2013, Pages

  West, Nick E J ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

Acute coronary syndromes; Antiplatelet therapies; Coronary intervention; ECG; Guidelines; Microvascular obstruction; NSTEMI; PCI; PPCI; Stem cell therapy; STEMI

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HIRULOG; PRASUGREL; RIVAROXABAN; TICAGRELOR;

ACUTE CORONARY SYNDROME; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; BALLOON OCCLUSION; CAUSE OF DEATH; CELL THERAPY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY DISEASE; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAPHY; FOLLOW UP; HEART ARREST; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE NECROSIS; HEART PROTECTION; HIGH RISK PATIENT; HUMAN; MAINTENANCE THERAPY; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; THROMBECTOMY; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ANTICOAGULANTS; ARRHYTHMIAS, CARDIAC; BONE MARROW TRANSPLANTATION; ELECTROCARDIOGRAPHY; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MYOCARDIAL INFARCTION; ORGAN SPARING TREATMENTS; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT;

EID: 84873624220     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs462     Document Type: Review

References (22)

1. The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-2619.
2. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BS, White HD. The Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Eur Heart J 2012;33:2551-2567; Circulation 2012;126: 2020-2035.
3. Kalesan B, Pilgrim T, Heinimann K, Raber L, Stefanini GG, Valgimigli M, da Costa BR, Mach F, Luscher TF, Meier B, Windecker S, Juni P. Comparison of drug-eluting stents with bare metal stents in patients with ST-segment elevation myocardial infarction. Eur Heart J 2012;33:977-987.
4. Jneid H, Anderson JL, Wright RS, Adams CS, Bridges CR, Casey DE, Ettinger SM, Fesmire FM, Ganiats TG, Lincoff AM, Peterson ED, Philippides GJ, Theroux P, Wenger NK, Zidar JP. 2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infraction (Updating the 2007 Guideline and Replacing the 2011 Focused Update). A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2012;60: 645-681.
5. Widimsky P, Roha'c F, Sta'sek J, Kala P, Rokyta R, Kuzmanov B, Jakl M, Poloczek M, Kanovsky J, Bernat I, Hlinomaz O, Belohla'vek J, Kra'l A, Mra'zek V, Grigorov V, Djambazov S, Petr R, Knot J, B?'lkova' D, Fischerova' M, Vondra'k K, Maly M, Lorencova' A. Primary angioplasty in acute myocardial infarction with right bundle branch block: should new onset right bundle branch block be added to future guidelines as an indication for reperfusion therapy? Eur Heart J 2012;33: 86-95.
6. Wong CK, Gao W, Stewart RA, French JK, Aylward PE, White HD, HERO-2 Investigators. The prognostic meaning of the full spectrum of aVR ST-segment changes in acute myocardial infarction. Eur Heart J 2012;33:384-392.
7. Antoni L, Boden H, Delgado V, Boersma E, Fox K, Schalij MJ, Bax JJ. Relationship between discharge heart rate and mortality in patients after myocardial infarction treated with primary percutaneous coronary intervention. Eur Heart J 2012;33: 96-102.
8. Hoffmann U, Truong QA, Schoenfeld DA, Chou ET, Woodard PK, Nagurney JT, Pope HJ, Hauser TH, White CS, Weiner SG, Kalanjian S, Mullins ME, Mikati I, Peacock WF, Zakroysky P, Hayden D, Goehler A, Lee H, Gazelle GS, Wiviott SD, Fleg JL, Udelson JE, ROMICAT-II Investigators. Coronary CT angiography versus standard evaluation in acute chest pain. N Engl J Med 2012;367: 299-308.
9. Litt HI, Gatsonis C, Snyder B, Singh H, Miller CD, Entrikin DW, Leaming JL, Gavin LJ, Pacella CB, Hollander JE. CT angiography for safe discharge of patients with possible acute coronary syndromes. N Engl J Med 2012;366:1393-1403.
10. Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Burton P, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM, ATLAS ACS 2-TIMI 51 Investigators. Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med 2012;366:9-19.
11. Trenk D, Stone GW, Gawaz M, Kastrati A, Angiolillo DJ, Muller U, Richardt G, Jakubowski JA, Neumann FJ. A randomized trail of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study. J Am Coll Cardiol 2012;59:2159-2164.
12. Roe MT, Armstrong PW, Fox KA, White HD, Prabhakaran D, Goodman SG, Cornel JH, Bhatt DL, Clemmensen P, Martinez F, Ardissino D, Nicolau JC, Boden WE, Gurbel PA, Ruzyllo W, Dalby AJ, McGuire DK, Leiva-Pons JL, Parkhomenko A, Gottlieb S, Topacio GO, Hamm C, Pavlides G, Goudev AR, Oto A, Tseng CD, Merkely B, Gasparovic V, Corbalan R, Cinteza? M, McLendon RC, Winters KJ, Brown EB, Lokhnygina Y, Aylward PE, Huber K, Hochman JS, Ohman EM, TRILOGY ACS Investigators. Prasugrel versus clopidogrel for acute coronary syndromes without revascularisation. N Engl J Med 2012; 367:1297-1309.
13. Ndrepepa G, Neumann FJ, Deliargyris EN, Mehran R, Mehilli J, Ferenc M, Schulz S, Schomig A, Kastrati A, Stone GW. Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 Trials. Circ Cardiovasc Interv 2012;5:705-712.
14. Stone GW, Maehara A, Witzenbichler B, Godlewski J, Parise H, Dambrink JH, Ochala A, Carlton TW, Cristea E, Wolff SD, Brener SJ, Chowdhary S, El-Omar M, Neunteufl T, Metzger DC, Karwoski T, Dizon JM, Mehran R, Gibson CM, INFUSE-AMI Investigators. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. JAMA 2012;307:1817-1826.
15. Thiele H, Wo hrle J, Hambrecht R, Rittger H, Birkemeyer R, Lauer B, Neuhaus P, Brosteanu O, Sick P, Wiemer M, Kerber S, Kleinertz K, Eitel I, Desch S, Schuler G. Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial. Lancet 2012;379:923-931.
16. Thiele H, Wo hrle J, Suenkel H, Meissner J, Kerber S, Lauer B, Pauschinger M, Birkemeyer R, Axthelm C, Zimmermann R, Neuhaus P, Brosteanu O, Desch S, Gutberlet M, Schuler G, Eitel I, AIDA STEMI Investigators. Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention. Cardiac magnetic resonance substudy of the AIDA STEMI trial. Presented at TCT 2012, Miami, 25 October.
17. Stone GW, Abizaid A, Silber S, Dizon JM, Merkely B, Cosat RA, Kornowski R, Abizaid A, Wojdyla R, Maehara A, Dressler O, Brener SJ, Bar E, Dudel D. Prospective, randomised, multicenter evaluation of a polyethylene terephthalate micronet mesh-covered stent (MGuard) in ST-segment elevation myocardial infarction. The MASTER Trial. J Am Coll Cardiol. doi:pii: S0735-1097(12)04506-8. 1016/j.jacc.2012.09.004. Published online ahead of print 28 September 2012.
18. Zhou C, Yao Y, Zheng Z, Gong J,WangW, Hu S, Li L. Stenting technique, gender, and age are associated with cardioprotection by ischaemic postconditioning in primary coronary intervention: a systematic review of 10 randomized trials. Eur Heart J 2012;33:3070-3077.
19. Hahn J-Y, Gwon H-C, POST Trial Investigators. Effect of postconditioning on myocardial reperfusion during primary percutaneous coronary intervention. Presented at TCT 2012. Miami, 25 October.
20. Surder D. Intracoronary infusion of BM-MNC early or late after AMI-4 months results of the Swiss-AMI trial. Presented at AHA 2012. Los Angeles, 6 November.
21. Traverse JH, Henry TD, Pepine CJ, Willerson JT, Zhao DXM, Ellis SG, Forder JR, Anderson RD, Hatzopoulos AK, Penn MS, Perin EC, Chambers J, Baran KW, Raveendran G, Lambert C, Lerman A, Simon DI, Vaughan DE, Lai D, Gee AP, Taylor DA, Cogle CR, Thomas JD, Olson RE, Bowman S, Francescon J, Geither C, Handberg E, Kappenman C, Westbrook L, Piller LB, Simpson LM, Baraniuk S, Loghin C, Aguilar D, Richman S, Zierold C, Spoon DB, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moye L, Simari RD, for the Cardiovascular Cell Therapy Research Network (CCTRN). Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction. The TIME Randomized Trial. JAMA 2012;308:2380-2389.
22. Kang H-J, Kim M-K, Lee H-Y, Park K-W, Lee W, Cho Y-S, Koo B-K, Choi D-J, Park Y-B, Kim H-S. Five-year results of intracoronary infusion of the mobilized peripheral blood stem cells by granulocyte colony-stimulating factor in patients with myocardial infarction. Eur Heart J 2012;33:3062-3069.